These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34117362)

  • 41. WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade.
    Yu X; Mao R; Feng W; Zhao Y; Qin J; Yang Y; Wang A; Shi Z
    Exp Cell Res; 2021 Dec; 409(1):112871. PubMed ID: 34672999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
    Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
    Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UGT2B17 and miR-224 contribute to hormone dependency trends in adenocarcinoma and squamous cell carcinoma of esophagus.
    Lian X; Baranova A; Ngo J; Yu G; Cao H
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31164411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma.
    Zhang W; Zhou Y; Li C; Xu S; Li M; Liu W; Ma Y; Wang H
    Anal Cell Pathol (Amst); 2020; 2020():2872479. PubMed ID: 33381388
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade.
    Meng RY; Jin H; Nguyen TV; Chai OH; Park BH; Kim SM
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OPA Interacting Protein 5 Antisense RNA 1 Expedites Cell Migration and Invasion Through FOXM1/ Wnt/β-Catenin Pathway in Pancreatic Cancer.
    Shi C; Zhang H; Wang M; Tian R; Li X; Feng Y; Peng F; Qin R
    Dig Dis Sci; 2022 Mar; 67(3):915-924. PubMed ID: 33782807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression.
    Wang L; Zhang Z; Yu X; Li Q; Wang Q; Chang A; Huang X; Han X; Song Y; Hu J; Pang L; Hou J; Li F
    Cancer Lett; 2020 Jan; 468():14-26. PubMed ID: 31600529
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway.
    Weng YC; Ma J; Zhang J; Wang JC
    Cancer Biol Ther; 2019; 20(3):368-380. PubMed ID: 30580676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. lncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the Wnt signaling pathway.
    Wang X; Gao Z; Liao J; Shang M; Li X; Yin L; Pu Y; Liu R
    J Toxicol Environ Health A; 2016; 79(9-10):407-18. PubMed ID: 27267823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.
    Yang J; Jiang Y; He R; Liu W; Yang M; Tao L; Fu X; Shen Y; Li J; Liu D; Huo Y; Zhang J; Hua R; Zhang Z; Sun Y
    J Immunol Res; 2019; 2019():8656282. PubMed ID: 31583260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression.
    Dong D; Zhang W; Xiao W; Wu Q; Cao Y; Gao X; Huang L; Wang Y; Chen J; Wang W; Zhan Q
    Cancer Res; 2021 Feb; 81(4):910-922. PubMed ID: 33323378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulated MEG3 contributes to tumour progression and poor prognosis in oesophagal squamous cell carcinoma by interacting with miR-4261, downregulating DKK2 and activating the Wnt/β-catenin signalling.
    Ma J; Li TF; Han XW; Yuan HF
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1513-1523. PubMed ID: 30990378
    [TBL] [Abstract][Full Text] [Related]  

  • 55. DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway.
    Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y
    Int J Oncol; 2020 May; 56(5):1115-1128. PubMed ID: 32319588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoter hypermethylation-mediated downregulation of tumor suppressor gene SEMA3B and lncRNA SEMA3B-AS1 correlates with progression and prognosis of esophageal squamous cell carcinoma.
    Dong Z; Liang X; Wu X; Kang X; Guo Y; Shen S; Liang J; Guo W
    Clin Exp Metastasis; 2019 Jun; 36(3):225-241. PubMed ID: 30915595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
    Mao L; Le S; Jin X; Liu G; Chen J; Hu J
    Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
    J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. YY1-induced upregulation of FOXP4-AS1 and FOXP4 promote the proliferation of esophageal squamous cell carcinoma cells.
    Li Y; Li T; Yang Y; Kang W; Dong S; Cheng S
    Cell Biol Int; 2020 Jul; 44(7):1447-1457. PubMed ID: 32159250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
    Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
    Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.